Avicena LVDP Validation Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 406 participants.

Also called NCT05633004

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 406 participants (enrolled count) (from the registry)
Sponsor
Ventric Health, LLC (from the registry)
Registry
  • NCT NCT05633004
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05633004. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-27 (actual); primary completion 2022-09-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Avicena LVDP Validation Study
Condition
Heart Failure
Intervention (Device)
Vivio
Lead sponsor
Ventric Health, LLC (class: industry)

Record details

Record id
cardio:ct-nct05633004
Content hash
1dea17d55a8332ab45da83a09d2ca75361ae0ef6591608d109059861239639c3